Logo image of ALCAB.PA

CABASSE SA (ALCAB.PA) Stock Fundamental Analysis

EPA:ALCAB - FR001400DIY6 - Common Stock

0.0316 EUR
0 (-11.73%)
Last: 9/2/2025, 7:00:00 PM
Fundamental Rating

1

Overall ALCAB gets a fundamental rating of 1 out of 10. We evaluated ALCAB against 34 industry peers in the Household Durables industry. ALCAB has a bad profitability rating. Also its financial health evaluation is rather negative. ALCAB is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year ALCAB has reported negative net income.
In the past year ALCAB has reported a negative cash flow from operations.
In the past 5 years ALCAB always reported negative net income.
The reported operating cash flow has been mixed in the past 5 years: ALCAB reported negative operating cash flow in multiple years.
ALCAB.PA Yearly Net Income VS EBIT VS OCF VS FCFALCAB.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -500K -1M -1.5M -2M -2.5M

1.2 Ratios

With a Return On Assets value of -29.70%, ALCAB is not doing good in the industry: 91.18% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -29.7%
ROE N/A
ROIC N/A
ROA(3y)-17.15%
ROA(5y)-11.69%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALCAB.PA Yearly ROA, ROE, ROICALCAB.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

ALCAB has a Gross Margin of 59.19%. This is amongst the best in the industry. ALCAB outperforms 82.35% of its industry peers.
ALCAB's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for ALCAB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.05%
GM growth 5Y1.91%
ALCAB.PA Yearly Profit, Operating, Gross MarginsALCAB.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40

More info and screens

0

2. Health

2.1 Basic Checks

The number of shares outstanding for ALCAB has been increased compared to 1 year ago.
Compared to 5 years ago, ALCAB has more shares outstanding
Compared to 1 year ago, ALCAB has a worse debt to assets ratio.
ALCAB.PA Yearly Shares OutstandingALCAB.PA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
ALCAB.PA Yearly Total Debt VS Total AssetsALCAB.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -0.66, we must say that ALCAB is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.66, ALCAB is doing worse than 91.18% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -0.66
ROIC/WACCN/A
WACCN/A
ALCAB.PA Yearly LT Debt VS Equity VS FCFALCAB.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 2M 4M

2.3 Liquidity

A Current Ratio of 0.69 indicates that ALCAB may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.69, ALCAB is doing worse than 94.12% of the companies in the same industry.
ALCAB has a Quick Ratio of 0.69. This is a bad value and indicates that ALCAB is not financially healthy enough and could expect problems in meeting its short term obligations.
ALCAB's Quick ratio of 0.33 is on the low side compared to the rest of the industry. ALCAB is outperformed by 94.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.69
Quick Ratio 0.33
ALCAB.PA Yearly Current Assets VS Current LiabilitesALCAB.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

ALCAB shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.20%.
ALCAB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -27.58%.
Measured over the past years, ALCAB shows a small growth in Revenue. The Revenue has been growing by 1.22% on average per year.
EPS 1Y (TTM)-18.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-52957.14%
Revenue 1Y (TTM)-27.58%
Revenue growth 3Y-15.19%
Revenue growth 5Y1.22%
Sales Q2Q%-40.91%

3.2 Future

ALCAB is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -51.09% yearly.
Based on estimates for the next years, ALCAB will show a very negative growth in Revenue. The Revenue will decrease by -41.37% on average per year.
EPS Next Y-258.45%
EPS Next 2Y-51.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-63.34%
Revenue Next 2Y-41.37%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ALCAB.PA Yearly Revenue VS EstimatesALCAB.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M
ALCAB.PA Yearly EPS VS EstimatesALCAB.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ALCAB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year ALCAB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALCAB.PA Price Earnings VS Forward Price EarningsALCAB.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALCAB.PA Per share dataALCAB.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1

4.3 Compensation for Growth

ALCAB's earnings are expected to decrease with -51.09% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-51.09%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALCAB does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CABASSE SA

EPA:ALCAB (9/2/2025, 7:00:00 PM)

0.0316

0 (-11.73%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap289.14K
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.23
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0.74
BVpS-0.15
TBVpS-0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -29.7%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.19%
FCFM N/A
ROA(3y)-17.15%
ROA(5y)-11.69%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.05%
GM growth 5Y1.91%
F-Score2
Asset Turnover0.78
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.69
Quick Ratio 0.33
Altman-Z -0.66
F-Score2
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-18.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-52957.14%
EPS Next Y-258.45%
EPS Next 2Y-51.09%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-27.58%
Revenue growth 3Y-15.19%
Revenue growth 5Y1.22%
Sales Q2Q%-40.91%
Revenue Next Year-63.34%
Revenue Next 2Y-41.37%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-71.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-74.35%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-700%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-700%
OCF growth 3YN/A
OCF growth 5YN/A